Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / Senate Bills / S. 2315

S. 2315

To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2018-01-1785.3K⠃⠗⠋
Reported in Senate2018-05-14170.5K⠃⠗⠋